MPP And IGBA Initiatives Bolster COVID-19 Access
18 Companies Sign Up To MPP Pledge
The Medicines Patent Pool and the International Generic and Biosimilar medicines Association have announced separate initiatives with the continued intention to facilitate access to COVID-19 treatments and vaccines, as the global threat from the novel coronavirus pandemic continues.
You may also be interested in...
C-TAP, the voluntary initiative aimed at making vaccines, tests, treatments and other health technologies to fight COVID-19 accessible to all, has been launched by the WHO, in partnership with Costa Rica.
The IGBA has lent its backing to the Access to COVID-19 Tools (ACT) Accelerator initiative launched by the WHO that is aimed at speeding the development and production of – as well as access to – essential health technologies for addressing the coronavirus pandemic.
The Medicines Patent Pool has expanded its mandate to include treatments that will aid the global response to the coronavirus pandemic.